TY  - GEN
T1  - On the admissibility of Biological Equivalence Tests during the patent term for obtaining a regulatory approval for patented drugs by third parties :a study in German and comparative /
AU  - Straus, Joseph,
VL  - 1998 Vol 23 No 6 pages 211-246
N1  - - The issue of admissibility of clinical trials related to pharmaceutically active ingredients petented to third parties and eventually aimed also at obtaining regulatory marketing authorization since some years has attracted enormous attention. This is witnessed by a remarkable number of court decisions handed down in various countries, by numerous articles published in leading law and economic journals, as well as by legal actions initiated with the World Trade Organization (WTO);.
ID  - 22750
KW  - Patents
KW  - PATENTS : PATENTABILITY : PHARMACEUTICAL PRODUCTS
KW  - BIOEQUIVALENCY TRIALS : EUROPEAN COURT OF JUSTICE
KW  - BIOEQUIVALENCY TRIALS : GERMAN CASE LAW
KW  - BIOEQUIVALENCY TRIALS : INTERNATIONAL LAW
TI  - On the admissibility of Biological Equivalence Tests during the patent term for obtaining a regulatory approval for patented drugs by third parties :a study in German and comparative /
ER  -